Latest Insider Transactions at Tabula Rasa Health Care, Inc. (TRHC)
This section provides a real-time view of insider transactions for Tabula Rasa Health Care, Inc. (TRHC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Tabula Rasa HealthCare, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Tabula Rasa HealthCare, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 03
2023
|
Ronald Paul Mitchell |
SELL
Sale (or disposition) back to the issuer
|
Direct |
79,332
-61.28%
|
-
|
Nov 03
2023
|
Michael J. Purcell |
SELL
Sale (or disposition) back to the issuer
|
Direct |
139,322
-81.77%
|
-
|
Nov 03
2023
|
Pamela Schweitzer |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
9,784
-100.0%
|
-
|
Nov 03
2023
|
Pamela Schweitzer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
79,220
-83.82%
|
-
|
Nov 03
2023
|
Jonathan David Schwartz |
SELL
Sale (or disposition) back to the issuer
|
Direct |
78,388
-61.21%
|
-
|
Nov 03
2023
|
Dennis Helling |
SELL
Sale (or disposition) back to the issuer
|
Direct |
112,109
-62.21%
|
-
|
Nov 03
2023
|
Michael Anthony Bruno CHIEF ACCOUNTING OFFICER |
SELL
Sale (or disposition) back to the issuer
|
Direct |
22,955
-76.08%
|
-
|
Nov 03
2023
|
Thomas Cancro CHIEF FINANCIAL OFFICER |
SELL
Sale (or disposition) back to the issuer
|
Direct |
304,092
-52.12%
|
-
|
Nov 03
2023
|
Michael Greenhalgh CHIEF OPERATING OFFICER |
SELL
Sale (or disposition) back to the issuer
|
Direct |
586,984
-45.12%
|
-
|
Nov 03
2023
|
Brian W Adams CHIEF EXECUTIVE OFFICER |
SELL
Sale (or disposition) back to the issuer
|
Direct |
767,311
-44.98%
|
-
|
Nov 03
2023
|
Richard W. Rew Ii CHIEF LEGAL OFFICER, SECRETARY |
SELL
Sale (or disposition) back to the issuer
|
Direct |
63,657
-70.0%
|
-
|
Nov 03
2023
|
Indaba Capital Management, L.P. Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
6,599,966
-100.0%
|
$65,999,660
$10.5 P/Share
|
Nov 03
2023
|
Samira Beckwith |
SELL
Sale (or disposition) back to the issuer
|
Direct |
88,299
-85.48%
|
-
|
Nov 03
2023
|
Kathrine O'Brien |
SELL
Sale (or disposition) back to the issuer
|
Direct |
96,689
-62.59%
|
-
|
Jun 28
2023
|
Michael Greenhalgh CHIEF OPERATING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
14,194
-3.74%
|
$99,358
$7.69 P/Share
|
Jun 28
2023
|
Michael Greenhalgh CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+6.18%
|
$75,000
$3.11 P/Share
|
Jun 28
2023
|
Brian W Adams CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
25,647
-5.13%
|
$179,529
$7.69 P/Share
|
Jun 28
2023
|
Brian W Adams CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
42,153
+7.77%
|
$126,459
$3.11 P/Share
|
Jun 09
2023
|
Indaba Capital Management, L.P. Director |
BUY
Grant, award, or other acquisition
|
Indirect |
25,641
+0.39%
|
-
|
Jun 09
2023
|
Pamela Schweitzer |
BUY
Grant, award, or other acquisition
|
Direct |
25,641
+24.45%
|
-
|
Jun 09
2023
|
Ronald Paul Mitchell |
BUY
Grant, award, or other acquisition
|
Direct |
25,641
+24.43%
|
-
|
Jun 09
2023
|
Kathrine O'Brien |
BUY
Grant, award, or other acquisition
|
Direct |
25,641
+20.96%
|
-
|
Jun 09
2023
|
Michael J. Purcell |
BUY
Grant, award, or other acquisition
|
Direct |
25,641
+15.54%
|
-
|
Jun 09
2023
|
Dennis Helling |
BUY
Grant, award, or other acquisition
|
Direct |
25,641
+18.61%
|
-
|
Jun 09
2023
|
Jonathan David Schwartz |
BUY
Grant, award, or other acquisition
|
Direct |
25,641
+24.65%
|
-
|
Jun 09
2023
|
Samira Beckwith |
BUY
Grant, award, or other acquisition
|
Direct |
25,641
+22.55%
|
-
|
Apr 19
2023
|
Michael Greenhalgh CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
41,667
+10.52%
|
-
|
Apr 19
2023
|
Richard W. Rew Ii CHIEF LEGAL OFFICER, SECRETARY |
BUY
Grant, award, or other acquisition
|
Direct |
25,463
+50.0%
|
-
|
Apr 19
2023
|
Thomas Cancro CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
37,037
+12.97%
|
-
|
Apr 19
2023
|
Brian W Adams CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
55,556
+10.82%
|
-
|
Mar 23
2023
|
Michael J. Purcell |
BUY
Grant, award, or other acquisition
|
Direct |
25,167
+18.13%
|
-
|
Jan 12
2023
|
Brian W Adams CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,409
-0.59%
|
$12,045
$5.02 P/Share
|
Jan 11
2023
|
Brian W Adams CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,886
-0.46%
|
$7,544
$4.95 P/Share
|
Jan 02
2023
|
Brian W Adams CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
18,292
-4.3%
|
$73,168
$4.95 P/Share
|
Jan 01
2023
|
Brian W Adams CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,560
-0.83%
|
$14,240
$4.95 P/Share
|
Dec 12
2022
|
Thomas Cancro CHIEF FINANCIAL OFFICER |
BUY
Open market or private purchase
|
Direct |
11,500
+5.16%
|
$46,000
$4.34 P/Share
|
Dec 09
2022
|
Michael J. Purcell |
SELL
Open market or private sale
|
Direct |
10,000
-10.15%
|
$40,000
$4.26 P/Share
|
Oct 10
2022
|
Ronald Paul Mitchell |
BUY
Grant, award, or other acquisition
|
Direct |
53,691
+50.0%
|
-
|
Sep 13
2022
|
Indaba Capital Management, L.P. Director |
BUY
Grant, award, or other acquisition
|
Indirect |
52,747
+0.8%
|
-
|
Sep 13
2022
|
Jonathan David Schwartz |
BUY
Grant, award, or other acquisition
|
Direct |
52,747
+50.0%
|
-
|
Aug 01
2022
|
Orsula V Knowlton CO-PRESIDENT |
BUY
Grant, award, or other acquisition
|
Indirect |
325,000
+31.99%
|
-
|
Aug 01
2022
|
Orsula V Knowlton CO-PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+29.64%
|
-
|
Aug 01
2022
|
Calvin H Knowlton CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Indirect |
200,000
+29.83%
|
-
|
Aug 01
2022
|
Calvin H Knowlton CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
325,000
+31.85%
|
-
|
Aug 01
2022
|
Michael Greenhalgh CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+32.42%
|
-
|
Aug 01
2022
|
Brian W Adams CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+31.81%
|
-
|
Jul 25
2022
|
Indaba Capital Management, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
59,262
+0.9%
|
$237,048
$4.28 P/Share
|
Jul 22
2022
|
Indaba Capital Management, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
293,292
+1.51%
|
$1,173,168
$4.24 P/Share
|
Jul 21
2022
|
Indaba Capital Management, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
1,000,000
+3.34%
|
$3,000,000
$3.92 P/Share
|
Jun 10
2022
|
Dennis Helling |
BUY
Grant, award, or other acquisition
|
Direct |
46,377
+34.91%
|
-
|